Feasibility Assessment of Recombinant Follicle-Stimulating Hormone (r-FSH) Production for Animal Reproduction.

• Grant number: 25/02845-5
• Support Opportunities: Research Grants - Innovative Research in Small Business - PIPE
• Start date: August 01, 2025
• End date: July 31, 2027
• Field of knowledge: Biological Sciences - Genetics - Animal Genetics
• Principal Investigator: Camillo Del Cistia Andrade
• Grantee: Camillo Del Cistia Andrade
• Associated research grant: 16/50326-8 - Recombinant equine chorionic gonadotropin (r-eCG) production in eukaryotic system for use in estrus synchronization protocols, AP.PIPE

Abstract

The follicle-stimulating hormone (FSH) is widely used in veterinary medicine, particularly in reproductive biotechnologies for cattle, sheep, and goats. It can be employed in embryo production programs (IVF) and protocols for estrous cycle synchronization, aiming at fixed-time artificial insemination (FTAI) and fixed-time embryo transfer (FTET). The purpose of this project is to develop a recombinant FSH through a cell-based platform tailored for the veterinary market. (AU)